Aga Khan University Hospital
Karachi, Sindh, 74800, Pakistan
Location status: Recruiting
NCT Number: NCT05927233
The goal of this study is to evaluate the effects of steroids on the early postoperative inflammatory response in patients undergoing elective pediatric congenital cardiac surgery, requiring cardiopulmonary bypass (CPB).
Interested in participating?
Request Info1 month–18 year
All sexes
Interventional
Phase 4
Karachi, Sindh, 74800, Pakistan
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 ml Methylprednisolone (30mg/kg) with a maximum dose of 500 mg
30 ml Normal saline
Time frame: Before the first dose of steroid), second sample will be drawn after immediately protamine infusion, third sample at 24 hours after CPB and the fourth sample will be drawn at 48 hours after CPB
serum levels of Interleukin- 6 will be measured using ELISA
Time frame: Before the first dose of steroid), second sample will be drawn after immediately protamine infusion, third sample at 24 hours after CPB and the fourth sample will be drawn at 48 hours after CPB
serum levels of CRP will be measured using ELISA
Time frame: Before the first dose of steroid), second sample will be drawn after immediately protamine infusion, third sample at 24 hours after CPB and the fourth sample will be drawn at 48 hours after CPB
Interested in participating?
Request InfoAga Khan University
Other
Effect of Methylprednisolone on Systemic Inflammatory Response and Clinical Parameters During Pediatric Congenital Open-Heart Surgery: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07771491
Cardiopulmonary Bypass, Cardiovascular Abnormalities
View Trial DetailsNCT03255564
Calprotectin, Cyanotic Heart Disease
London, United Kingdom
View Trial DetailsNCT02237014
Cyanotic Heart Disease
Stanford, California, United States
View Trial DetailsNCT07632131
Cardiopulmonary Bypass, Intensive Care Units
Fuzhou, Fujian, China
View Trial Details